TickrTalk0007 Posted - 2 days ago

$ZNTL under $5 soon

StockInvest_us Posted - 2 weeks ago

Signal alert: $ZNTL - Overbought Trend Short (Overvalued) https://stockinvest.us/l/iouFQWwJNA

Stock_Titan Posted - 2 weeks ago

$ZNTL Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024 https://www.stocktitan.net/news/ZNTL/zentalis-pharmaceuticals-to-highlight-preclinical-data-demonstrating-1h05wto1jt8p.html

Stock_Titan Posted - 2 weeks ago

$ZNTL Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/ZNTL/zentalis-pharmaceuticals-announces-inducement-grants-under-nasdaq-zyd9sq4qmhk3.html

AdiDasRom Posted - 03/22/24

$ZNTL Bullish

Ninja_Tradez Posted - 1 month ago

📢 $ZNTL - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://newsfilter.io/a/0f2c66c0f272405fea57b209aabffcb1

Stock_Titan Posted - 1 month ago

$ZNTL Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/ZNTL/zentalis-pharmaceuticals-announces-inducement-grants-under-nasdaq-nd3ojut7g6mw.html

_StockTrader Posted - 02/28/24

Real-Time Stock Data $ZNTL Price: 17.84 Volume: 701056 Market Cap: 1244324608 PE Ratio: -4.8306866 Stock data provided by: AITX

Stock_Titan Posted - 02/28/24

$ZNTL Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/ZNTL/zentalis-pharmaceuticals-to-participate-in-upcoming-investor-of1qwvlslvk0.html

briefingcom Posted - 02/27/24

$ZNTL: Zentalis Pharma beats by $0.13 https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240227070711ZNTL&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

DonCorleone77 Posted - 02/27/24

$ZNTL Zentalis reports 2023 EPS ($4.47), consensus ($4.54) "Zentalis is making remarkable progress in advancing our clinical development program for azenosertib, our potentially groundbreaking WEE1 inhibitor, across various tumor types," stated Kimberly Blackwell, M.D., Chief Executive Officer of Zentalis. "In November 2023, we disclosed promising clinical data demonstrating the potential of azenosertib as an effective monotherapy in ovarian cancer and uterine serous carcinoma. Our team is diligently executing a clinical strategy, which is firmly on track, designed to rapidly bring this promising therapeutic option to patients with gynecological cancers that continue to have a poor prognosis based on currently available treatment options. We anticipate an exciting and data-rich period ahead during the remainder of 2024 and into 2025 where we plan to share multiple clinical datasets to help further demonstrate the potential of azenosertib in multiple cancer types as a monotherapy.."

epsguid Posted - 02/27/24

$ZNTL reported a loss of $0.76, consensus was ($0.92) via @eWhispers #epsbeat http://eps.sh/d/zntl

Stock_Titan Posted - 02/27/24

$ZNTL Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates https://www.stocktitan.net/news/ZNTL/zentalis-pharmaceuticals-reports-full-year-2023-financial-results-bedv9y8e57mt.html

TickerDD_com Posted - 02/26/24

From 2/16/2024, looking back across 22 Month-Ends for ZNTL, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ZNTL #ZNTL #ZNTLStock #TickerDD #ZNTLPrice https://www.youtube.com/watch?v=a5N_W1gGL_A

StockInvest_us Posted - 02/22/24

Signal alert: $ZNTL - PivotPoint bottom https://stockinvest.us/l/jflkHE2OSj

TalkMarkets Posted - 02/22/24

#MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential $MAIA Also $ZNTL https://talkmarkets.com/content/stocks--equities/maia-biotechnology-undervalued-with-eye-popping-cancer-data-and-partnership-potential?post=430910&userid=166882

AdiDasRom Posted - 02/20/24

$ZNTL

AdiDasRom Posted - 2 months ago

$ZNTL

Stock_Titan Posted - 2 months ago

$ZNTL Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference https://www.stocktitan.net/news/ZNTL/zentalis-pharmaceuticals-to-participate-in-the-oppenheimer-ex1yalosjkp8.html

insiderbuyingselling Posted - 2 months ago

$ZNTL new insider selling: 1173 shares. http://insiderbuyingselling.com/?t=ZNTL

Broview Posted - 2 months ago

$ZNTL lack of strategy?

TickrTalk0007 Posted - 2 months ago

$ZNTL President Cam Gallagher has been selling non stop since the company went private and collects a nice paycheck. Grear setup to use public market to get rich!

TickrTalk0007 Posted - 2 months ago

$ZNTL $2 stock

insiderbuyingselling Posted - 2 months ago

$ZNTL new insider selling: 8669 shares. http://insiderbuyingselling.com/?t=ZNTL

insiderbuyingselling Posted - 2 months ago

$ZNTL new insider selling: 3310 shares. http://insiderbuyingselling.com/?t=ZNTL

TickrTalk0007 Posted - 2 months ago

$ZNTL

Last10K Posted - 01/25/24

$ZNTL just filed with the SEC a Listing Status, a Event for Officers, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/ZNTL/0001725160-24-000012.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ZNTL

StockAutomatePro Posted - 01/21/24

$ZNTL Stock headed for a downturn according to the chart. We alerted the SELL signal at $15.7 and we were able to close this one with profit at $12.899 📊

tickeron Posted - 3 months ago

How will this affect the market? $ZNTL Aroon Indicator entered an Uptrend. View odds of downtrend. https://srnk.us/go/4968592

dividendinvestorbyeagle Posted - 3 months ago

$ZNTL close decreased > 10% (Zentalis Pharmaceuticals Inc) https://www.dividendinvestor.com/dividend-news/?symbol=zntl http://dlvr.it/T1K5jB